Unlocking the Potential: The Remarkable Benefits of Corazon TAVR Accreditation

In the ever-evolving field of healthcare, advancements in technology have paved the way for innovative treatments that promise better outcomes and improved quality of life for patients. Transcatheter Aortic Valve Replacement (TAVR) is one such revolutionary procedure that has transformed the management of aortic valve diseases, offering a less invasive alternative to traditional open-heart surgery.…

Optimizing your TAVR Program

A recent article in Circulation, published online ahead of print, addressed a retrospective cohort study using data from the STS/ACC TVT Registry which concluded that significant differences in the quality of TAVR care exists, particularly, variations in mortality and major complications after TAVR procedures in the United States (Desai et al, 2021). The study also…

The Business Case for TAVR

WHY TAVR? When TAVR first emerged, this procedure was primarily performed in academic, quaternary, tertiary-type centers. But as time goes on, more and more community-based open-heart centers are offering TAVR as well. There is no question that TAVR is growing at a rapid pace, but there are many more entrants into the market. At Corazon…

TAVR: The New Standard of Care?

The new ACC valvular heart disease guidelines, released in 2020, recognize the expanding role of transcatheter aortic valve replacement (TAVR) and the intervention choices available for a patient with severe aortic stenosis.  This focused update provides evidence-based recommendations to optimize care and management of patients with valvular heart disease, and highlights the expanding indications for…